Capital Advisors, Ltd. LLC Tg Therapeutics, Inc. Transaction History
Capital Advisors, Ltd. LLC
- $793 Million
- Q4 2024
A detailed history of Capital Advisors, Ltd. LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 76 shares of TGTX stock, worth $3,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76
Previous 76
-0.0%
Holding current value
$3,030
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
373Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$454 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$367 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$127 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$111 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.79B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...